Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Feb 27, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Inc / Ma
| -5.47K |
$428.45 | -$2,344,892.31 | -9.00% | 55.33K |
Feb 23 - Feb 26
|
Scheduled
| ||||||
Vertex Pharmaceuticals Inc / Ma
| -3.19K |
$421.77 | -$1,345,868.07 | -4.99% | 60.8K |
Feb 21
|
Scheduled
| ||||||
Vertex Pharmaceuticals Inc / Ma
| -10.38K |
$421.82 | -$4,376,408.98 | -13.95% | 63.99K |
Feb 16 - Feb 20
|
Scheduled
| ||||||
Vertex Pharmaceuticals Inc / Ma
| -5.24K |
$421.20 | -$2,208,793.56 | -6.59% | 74.36K |
Feb 9 - Feb 12
|
Scheduled
| ||||||
Vertex Pharmaceuticals Inc / Ma
| 20.79K |
—
|
—
| +35.36% | 79.61K |
Feb 6 - Feb 7
| |||||||
Vertex Pharmaceuticals Inc / Ma
| -35.00 |
$369.92 | -$12,947.20 | -0.06% | 58.81K |
Nov 15
|
Scheduled
| ||||||
Vertex Pharmaceuticals Inc / Ma
| -10.03K |
$350.00 | -$3,510,850.00 | -14.57% | 58.81K | +1 |
Aug 10
| ||||||
Eiger Biopharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 1
| |||||||
Vertex Pharmaceuticals Inc / Ma
| -2.47K |
$289.12 | -$713,548.16 | -3.58% | 66.52K | +1 |
Feb 24
| ||||||
Vertex Pharmaceuticals Inc / Ma
| -3.50K |
$292.85 | -$1,024,389.30 | -4.83% | 68.99K | +1 |
Feb 17
| ||||||
Vertex Pharmaceuticals Inc / Ma
| -7.27K |
$296.85 | -$2,157,492.45 | -9.11% | 72.48K | +1 |
Feb 10 - Feb 13
| ||||||
Vertex Pharmaceuticals Inc / Ma
| 24.73K |
—
|
—
| +37.42% | 90.8K | +1 |
May 17 - Feb 1
| ||||||
Eiger Biopharmaceuticals, Inc.
| 6K |
—
|
—
| +60.00% | 16K |
Mar 11
| |||||||
Vertex Pharmaceuticals Inc / Ma
| -7.37K |
$227.86 | -$1,678,872.48 | -13.26% | 48.21K | +1 |
Feb 24
| ||||||
Vertex Pharmaceuticals Inc / Ma
| -3.50K |
$232.51 | -$813,087.47 | -5.92% | 55.58K | +1 |
Feb 17
| ||||||
Vertex Pharmaceuticals Inc / Ma
| -2.49K |
$237.74 | -$592,210.34 | -4.05% | 59.08K | +1 |
Feb 10
| ||||||
Vertex Pharmaceuticals Inc / Ma
| 29.64K |
—
|
—
| +92.83% | 61.57K | +1 |
Feb 1
| ||||||
Vertex Pharmaceuticals Inc / Ma
| -51.00 |
$187.19 | -$9,546.78 | -0.16% | 31.93K | +1 |
Nov 15
|
Scheduled
| |||||
Vertex Pharmaceuticals Inc / Ma
| -45.00 |
$216.35 | -$9,735.87 | -0.11% | 40.13K | +1 |
May 17
|
Scheduled
| |||||
Vertex Pharmaceuticals Inc / Ma
|
0
|
$151.29 | -$503,149.46 |
—
| 40.13K | +1 |
Apr 27
|
Scheduled
| |||||
Eiger Biopharmaceuticals, Inc.
| 5K |
—
|
—
| +100.00% | 10K |
Mar 12
| |||||||
Vertex Pharmaceuticals Inc / Ma
| -6.53K |
$215.29 | -$1,406,268.62 | -14.00% | 40.13K | +1 |
Feb 24 - Feb 25
|
Scheduled
| |||||
Vertex Pharmaceuticals Inc / Ma
| -16.88K |
$211.79 | -$3,574,418.75 | -26.56% | 46.66K | +1 |
Feb 17 - Feb 18
|
Scheduled
| |||||
Vertex Pharmaceuticals Inc / Ma
| -4.46K |
$210.55 | -$939,067.80 | -6.56% | 63.54K | +1 |
Feb 11
|
Scheduled
| |||||
Vertex Pharmaceuticals Inc / Ma
| -2.42K |
$214.16 | -$518,481.36 | -3.44% | 68K | +1 |
Feb 10
| ||||||
Vertex Pharmaceuticals Inc / Ma
| 28.69K |
—
|
—
| +58.42% | 77.79K | +1 |
Dec 8 - Feb 3
| ||||||
Vertex Pharmaceuticals Inc / Ma
| -42.00 |
$223.53 | -$9,388.24 | -0.12% | 35.1K | +1 |
Nov 16
|
Scheduled
| |||||
Vertex Pharmaceuticals Inc / Ma
|
0
|
$182.40 | -$372,201.36 |
—
| 35.1K | +1 |
Aug 3
|
Scheduled
| |||||
Vertex Pharmaceuticals Inc / Ma
| -58.00 |
$284.41 | -$16,495.71 | -0.16% | 35.1K | +1 |
May 15
|
Scheduled
| |||||
Vertex Pharmaceuticals Inc / Ma
|
0
|
$207.25 | -$1,607,407.64 |
—
| 35.1K | +1 |
May 11
|
Scheduled
| |||||
Vertex Pharmaceuticals Inc / Ma
|
0
|
$203.58 | -$95,927.91 |
—
| 35.1K | +1 |
May 6
|
Scheduled
| |||||
Vertex Pharmaceuticals Inc / Ma
|
0
|
$190.75 | -$8,376,920.97 |
—
| 35.1K | +1 |
May 4 - May 5
|
Scheduled
| |||||
Eiger Biopharmaceuticals, Inc.
| 5K |
—
|
—
|
∞
| 5K |
Mar 12
| |||||||
Vertex Pharmaceuticals Inc / Ma
| -6.53K |
$236.28 | -$1,543,411.76 | -16.56% | 32.91K | +1 |
Feb 24 - Feb 25
|
Scheduled
| |||||
Vertex Pharmaceuticals Inc / Ma
| -6.75K |
$242.56 | -$1,637,553.18 | -14.61% | 39.45K | +1 |
Feb 17 - Feb 18
|
Scheduled
| |||||
Vertex Pharmaceuticals Inc / Ma
| -25.29K |
$243.60 | -$6,159,514.77 | -35.37% | 46.2K | +1 |
Feb 10 - Feb 11
|
Scheduled
| |||||
Vertex Pharmaceuticals Inc / Ma
| 35.29K |
—
|
—
| +97.52% | 71.48K | +1 |
Feb 5
| ||||||
Vertex Pharmaceuticals Inc / Ma
|
0
|
$160.01 | -$582,606.20 |
—
| 36.19K | +1 |
Feb 3
|
Scheduled
| |||||
Vertex Pharmaceuticals Inc / Ma
|
0
|
$172.07 | -$629,300.00 |
—
| 36.19K | +1 |
Jan 16
|
Scheduled
| |||||
Vertex Pharmaceuticals Inc / Ma
|
0
|
$169.57 | -$604,300.00 |
—
| 36.19K | +1 |
Jan 8
|
Scheduled
| |||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.